Literature DB >> 33830817

Secondary denervation is a chronic pathophysiologic sequela of volumetric muscle loss.

Jacob R Sorensen1, Daniel B Hoffman1, Benjamin T Corona2, Sarah M Greising1.   

Abstract

Volumetric muscle loss (VML) is the traumatic loss of muscle tissue that results in long-term functional impairments. Despite the loss of myofibers, there remains an unexplained significant decline in muscle function. VML injury likely extends beyond the defect area, causing negative secondary outcomes to the neuromuscular system, including the neuromuscular junctions (NMJs), yet the extent to which VML induces denervation is unclear. This study systematically examined NMJs surrounding the VML injury, hypothesizing that the sequela of VML includes denervation. The VML injury removed ∼20% of the tibialis anterior (TA) muscle in adult male inbred Lewis rats (n = 43), the noninjured leg served as an intra-animal control. Muscles were harvested up to 48 days post-VML. Synaptic terminals were identified immunohistochemically, and quantitative confocal microscopy evaluated 2,613 individual NMJ. Significant denervation was apparent by 21 and 48 days post-VML. Initially, denervation increased ∼10% within 3 days of injury; with time, denervation further increased to ∼22% and 32% by 21 and 48 days post-VML, respectively, suggesting significant secondary denervation. The appearance of terminal axon sprouting and polyinnervation were observed as early as 7 days post-VML, increasing in number and complexity throughout 48 days. There was no evidence of VML-induced NMJ size alteration, which may be beneficial for interventions aimed at restoring muscle function. This work recognizes VML-induced secondary denervation and poor remodeling of the NMJ as part of the sequela of VML injury; moreover, secondary denervation is a possible contributing factor to the chronic functional impairments and potentially an overlooked treatment target.NEW & NOTEWORTHY This work advances our understanding of the pathophysiologic complexity of volumetric muscle loss injury. Specifically, we identified secondary denervation in the muscle remaining after volumetric muscle loss injuries as a novel aspect of the injury sequela. Denervation increased chronically, in parallel with the appearance of irregular morphological characteristics and destabilization of the neuromuscular junction, which is expected to further confound chronic functional impairments.

Entities:  

Keywords:  innervation; neuromuscular junction; polyinnervation; skeletal muscle; sprouting

Mesh:

Year:  2021        PMID: 33830817      PMCID: PMC8354822          DOI: 10.1152/japplphysiol.00049.2021

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  89 in total

Review 1.  Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease.

Authors:  Tessa Gordon; Janka Hegedus; Siu Lin Tam
Journal:  Neurol Res       Date:  2004-03       Impact factor: 2.448

2.  Electrodiagnostic Evaluation of Individuals Implanted With Extracellular Matrix for the Treatment of Volumetric Muscle Injury: Case Series.

Authors:  Nami Han; Mohammad A Yabroudi; Kristen Stearns-Reider; Wendy Helkowski; Brian M Sicari; J Peter Rubin; Stephen F Badylak; Michael L Boninger; Fabrisia Ambrosio
Journal:  Phys Ther       Date:  2015-11-12

Review 3.  The neuromuscular junction: anatomical features and adaptations to various forms of increased, or decreased neuromuscular activity.

Authors:  Meredith H Wilson; Michael R Deschenes
Journal:  Int J Neurosci       Date:  2005-06       Impact factor: 2.292

Review 4.  Mechanisms controlling neuromuscular junction stability.

Authors:  Evelyne Bloch-Gallego
Journal:  Cell Mol Life Sci       Date:  2014-10-31       Impact factor: 9.261

Review 5.  Pathophysiology of Volumetric Muscle Loss Injury.

Authors:  Benjamin T Corona; Joseph C Wenke; Catherine L Ward
Journal:  Cells Tissues Organs       Date:  2016-11-09       Impact factor: 2.481

6.  Therapeutic Approaches for Volumetric Muscle Loss Injury: A Systematic Review and Meta-Analysis.

Authors:  Sarah M Greising; Benjamin T Corona; Christopher McGann; Jeremy K Frankum; Gordon L Warren
Journal:  Tissue Eng Part B Rev       Date:  2019-11-11       Impact factor: 6.389

7.  Neurobiology of peripheral nerve injury, regeneration, and functional recovery: from bench top research to bedside application.

Authors:  Wale Sulaiman; Tessa Gordon
Journal:  Ochsner J       Date:  2013

8.  Regenerating muscle fibers induce directional sprouting from nearby nerve terminals: studies in living mice.

Authors:  P van Mier; J W Lichtman
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

9.  Morphological and functional remodelling of the neuromuscular junction by skeletal muscle PGC-1α.

Authors:  Anne-Sophie Arnold; Jonathan Gill; Martine Christe; Rocío Ruiz; Shawn McGuirk; Julie St-Pierre; Lucía Tabares; Christoph Handschin
Journal:  Nat Commun       Date:  2014-04-01       Impact factor: 14.919

10.  Evaluation of the Therapeutic Potential of Human iPSCs in a Murine Model of VML.

Authors:  Jianbo Wu; Nadine Matthias; Shubhang Bhalla; Radbod Darabi
Journal:  Mol Ther       Date:  2020-09-06       Impact factor: 11.454

View more
  4 in total

Review 1.  Human muscle in gene edited pigs for treatment of volumetric muscle loss.

Authors:  Sarah M Greising; Joshua I Weiner; Daniel J Garry; David H Sachs; Mary G Garry
Journal:  Front Genet       Date:  2022-07-25       Impact factor: 4.772

2.  Retrospective characterization of a rat model of volumetric muscle loss.

Authors:  Connor P Dolan; Christopher L Dearth; Benjamin T Corona; Stephen M Goldman
Journal:  BMC Musculoskelet Disord       Date:  2022-08-26       Impact factor: 2.562

3.  The impact of bilateral injuries on the pathophysiology and functional outcomes of volumetric muscle loss.

Authors:  Connor P Dolan; Andrew R Clark; Jessica M Motherwell; Naveena B Janakiram; Michael S Valerio; Christopher L Dearth; Stephen M Goldman
Journal:  NPJ Regen Med       Date:  2022-10-15

Review 4.  The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease.

Authors:  Shama R Iyer; Sameer B Shah; Richard M Lovering
Journal:  Int J Mol Sci       Date:  2021-07-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.